Lilly Pacts Bar Telehealth Firms From Selling Copycat Zepbound
Summary by Bloomberg
2 Articles
2 Articles
All
Left
2
Center
Right
Lilly Pacts Bar Telehealth Firms From Selling Copycat Zepbound
Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, diminishing the likelihood of a partnership with one most visible players in the industry, Hims & Hers Health Inc.
·United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left2Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium